Business Wire

Mindbreeze Heralds a New Era of Data Usage with the Insight Workplace

Share

Mindbreeze, a leading global provider of AI-based knowledge management solutions, is taking company data interactions to the next level with the Insight Workplace. This solution uses AI agents to retrieve relevant information from different data sources in real time, facilitating access to knowledge while simultaneously making it easier to use. Through proactive knowledge management, companies benefit from significant time savings, both for complex tasks and routine processes. They also provide their teams with a better basis for making business-critical decisions.

Employees are constantly using different data sources to access important information for processes and decisions. These prevailing data silos make it difficult to unlock the full potential of AI and automation. This is where Mindbreeze comes in with its Insight Workplace. With its intuitive design and a combination of different artificial intelligence methods, the Insight Workplace makes it easy to interact with company data.

"The Insight Workplace concept was inspired by human communication. Employees should interact with our solution as they would with a competent colleague - in the sense of a conversation. If a question changes the way in which the answer is presented also changes, without the user having to switch to the environment," says Daniel Fallmann, founder and CEO of Mindbreeze.

"Imagine how easy it is to prepare meetings or sift through information for business-critical decisions. Instead of searching through numerous reports, you simply ask Mindbreeze the question "What is the current status of the customer project?" or "Which contracts expire at the end of the 3rd quarter?" The Insight Workplace immediately provides a contextualized and clearly presented answer. The AI agent selects the optimal visual representation in the background - be it a list, a diagram or a table - and which action should be executed next."

Mindbreeze Insight Workplace

The technological basis behind the Insight Workplace is Mindbreeze InSpire. The solution offers powerful insight services such as fact extraction, classification, LLMs and Natural Language Question Answering (NLQA). To provide the answers, Mindbreeze uses Retrieval Augmented Generation (RAG) to minimize hallucinations.

As an additive system, Mindbreeze InSpire (Insight Engine) can be easily integrated into existing IT landscapes (cloud, on-premises, SaaS) as well as seamlessly into work environments such as Outlook and SharePoint. More than 500 company data sources can be connected via the connectors provided.

In order maintain an overview in the Insight Workplace even during intensive use, queries are displayed in a structured manner in Insight Touchpoints and Insight Journeys:

  • Every question to Mindbreeze is saved in the Insight Workplace as an Insight Touchpoint. The Insight Touchpoints can updated at any time.
  • Insight Journeys cluster several touchpoints on one topic. In HR, for example, a Journey could contain all the questions about the onboarding process for new employees. New employees always receive the latest information without any further action, as the Journey is also updated immediately when it is called up again.

By using different methods of artificial intelligence and providing data in real time from all connected company data sources, the Insight Workplace offers a forward-looking platform for improved decision-making, collaboration and efficiency.

About Mindbreeze

Mindbreeze is a global leader in AI-powered enterprise intelligence, with headquarters in Europe and the US. Mindbreeze InSpire redefines how organizations access and utilize information. Powered by advanced AI, it transforms complex data into actionable insights, seamlessly connecting and analyzing information across systems.

Unlike traditional solutions, our AI agents deliver hyper-relevant, context-aware insights tailored to unique business needs, enabling smarter, faster decision-making. With unmatched integration capabilities, data security, and automation at its core, Mindbreeze InSpire maximizes the value of your information ecosystem while driving innovation.

Trusted by industry leaders and recognized for our cutting-edge technology, Mindbreeze leads the way in unlocking new dimensions of enterprise intelligence.

Learn more at www.mindbreeze.com or follow us on LinkedIn and X @Mindbreeze.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250227667353/en/

Contacts

Mindbreeze
Ulrike Kogler
+43 732 606162-620
pr@mindbreeze.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o

IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release

IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop

NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates

Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release

As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye